Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Autor: | Allen, Pamela B. 1, Savas, Hatice 2, 3, Evens, Andrew M. 4, Advani, Ranjana H. 5, Palmer, Brett 3, Pro, Barbara 3, Karmali, Reem 3, Mou, Eric 5, Bearden, Jeffrey 3, Dillehay, Gary 2, 3, Bayer, Robert A. 3, Eisner, Robert M. 3, Chmiel, Joan S. 3, 6, O'Shea, Kaitlyn 3, 6, Gordon, Leo I. 3, Winter, Jane N. 3, * |
---|---|
Zdroj: | In Blood 11 March 2021 137(10):1318-1326 |
Databáze: | ScienceDirect |
Externí odkaz: |